Action of AT1 receptor antagonists on angiotensin II-induced tone in human isolated subcutaneous resistance arteries

British Journal of Pharmacology

Volumn 127, Issue 8, 1999, Pages 1876-1882

  Garcha, Robinder S ^a   Sever, Peter S ^a   Hughes, Alun D ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Angiotensin II; AT1; Endothelin; Endothelium; Nitric oxide; Receptors

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 2 BUTYL 4 CHLORO 1 [[2' (1H TETRAZOL 5 YL) 4 BIPHENYLYL]METHYL] 5 IMIDAZOLECARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ARGININE METHYL ESTER; CANDESARTAN; ENDOTHELIN RECEPTOR ANTAGONIST; INDOMETACIN; LOSARTAN; PERHYDRO 1 AZEPINYLCARBONYLLEUCYL DEXTRO TRYPTOPHYL DEXTRO TRYPTOPHAN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; BENZIMIDAZOLE DERIVATIVE; IMIDAZOLE DERIVATIVE; TETRAZOLE DERIVATIVE; VASOCONSTRICTOR AGENT;

ARTERY ENDOTHELIUM; ARTERY TONE; ARTICLE; HUMAN; HUMAN TISSUE; ISOLATED ARTERY; MODEL; PRIORITY JOURNAL; RESISTANCE BLOOD VESSEL; ARTERY; DRUG ANTAGONISM; DRUG EFFECT; MUSCLE TONE; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ANGIOTENSIN II; ARTERIES; BENZIMIDAZOLES; ENDOTHELIUM, VASCULAR; HUMANS; IMIDAZOLES; LOSARTAN; MUSCLE TONUS; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; TETRAZOLES; VASOCONSTRICTOR AGENTS;

EID: 0032588149     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702722     Document Type: Article

References (49)

1. Bakris, G.I., & Re, R.N. (1993). Endothelin modulates angiotensin II-induced mitogenesis of human mesangial cells. Am. J. Physiol., 264, F937-F942.
2. Boulanger, C.M., Caputo, L. & Levy, B.I. (1995). Endothelial ATI-mediated release of nitric oxide decreases angiotensin II contractions in rat carotid artery. Hypertension. 26, 752-757.
3. Cachofeiro, V., Maeso, R., Rodrigo, E., Navarro, J., Ruilope, L.M. & Lahera, V. (1995). Nitric oxide and prostaglandins in the prolonged effects of Losartan and Ramipril in hypertension. Hypertension. 26, 236-243.
4. Chen, L., McNeill, J.R., Wilson, T.W. & Gopalakrishnan, V. (1995). Heterogeneity in vascular smooth muscle responsiveness to angiotensin II (role of endothelin). Hypertension. 26, 83-88.
5. Chiu, A.T., McCall, D.E., Aldrich, P.E. & Timmermans, P.B. (1990a). [3H]DUP 753, a highly potent and specific radioligand for the angiotensin II-1 receptor subtype. Biochem. Biophys. Res. Commun., 172, 1195-202.
6. Chiu, A.T., McCall, D.E., Ardecky, R.J., Duncia, J.V., Nguyen, T.T. & Timmermans, P.B. (1990b). Angiotensin II receptor subtypes and their selective nonpeptide ligands. Receptor, 1, 33-40.
7. Chiu, A.T., McCall, D.E., Price, W.A., Wong, P.C., Carini, D.J., Duncia, J.V., Wexler, R.R., Yoo, S.E., Johnson, A.L. & Timmermans, P.B. (1990c). Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent. J. Pharmacol. Exp. Ther., 252, 711-718.
8. Ciafre, S.A., D'Armiento, F.P., Di Gregorio, F., Colasanti, P., Di Benedetto, A., Langella, A., Di Ieso, N., Liguori, A., Colasanti, R. & Napoli, C. (1993). Angiotensin II stimulates endothelin-1 release from human endothelial cells. Recent Prog. Med., 84, 248-253.
9. Conover, W.J. (1980). Practical Nonparametric statistics 2nd edn. New York: John Wiley and sons.
10. Corriu, C., Bernard, S., Schott, C. & Stoclet, J.C. (1995). Effects of losartan on contractile responses of conductance and resistance arteries from rats. J. Cardiovasc. Pharmacol., 26, 688-692.
11. Cortes, S.F., Andriantsitohaina, R. & Stoclet, J.C. (1996). Alterations of cyclo-oxygenase and NO in responses to angiotensin II of resistance arteries from the spontaneously hypertensive rat. Br. J. Pharmacol., 119, 1635-1641.
12. De Gasparo, M., Husain, A., Alexander, W., Catt, K.J., Chiu, A.T., Drew, M., Goodfriend, T., Harding, J.W., Inagani, T. & Timmermans, P.B.M.W.M. (1995). Proposed update of angiotensin receptor nomenclature. Hypertension, 25, 924-927.
13. De Nicola, L., Blantz, R.C. & Gabbai, F.B. (1992). Nitric oxide and angiotensin II. J. Clin. Invest., 89, 1248-1256.
14. Dohi, Y., Hahn, A.W.A., Boulanger, C.M., Buhler, F.R. & Luscher, T.F. (1992). Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries. Hypertension, 19, 131-137.
15. Emori, T., Hirata, Y., Ohta, K., Kanno, K., Eguchii, S., Imai, T., Schichiri, M. & Marumo, F. (1991). Cellular mechanism of endothelin-1 release by angiotensin and vasopressin. Hypertension, 18, 165-170.
16. Gero, A. (1983). Desensitization, two-state receptors and pharmacological parameters. J. Theor. Biol., 103, 137-161.
17. Haberl, R.L. (1994). Role of angiotensin receptor subtypes in the response of rabbit brain arterioles to angiotensin. Stroke, 25, 1476-1479.
18. He, G.W., Shaw, J., Hughes, C.F., Yang, C.Q., Thomson, D.S., McCaughan, B., Hendle, P.N. & Baird, D.K. (1993). Predominant alpha 1-adrenoceptor-mediated contraction in the human internal mammary artery. J. Cardiovasc. Pharmacol. 21, 256-263.
19. 1 angiotensin receptor: identification of amino acid residues that determine binding of the antihypertensive drug losartan. J. Biol. Chem., 269, 16533-16536.
20. Jovanovic, A., Grbovic, L., Zikic, I. & Tulic, I. (1995). Characterization of arginine vasopressin actions in human uterine artery: lack of role of the vascular endothelium. Br. J. Pharmacol., 115, 1295-1301.
21. Juul, B., Aalkjaer, C. & Mulvany, M.J. (1987). Responses of femoral resistance vessels to angiotensin in vitro. Eur. J. Pharmacol., 135, 61-68.
22. Katz, B. & Thesleff, S. (1957). A study of the 'desensitization' produced by acetylcholine at the motor endplate. J. Physiol. (Lond.). 138, 63-80.
23. Kenakin, T.P. (1993). Pharmacologic analysis of drug-receptor interaction. 2nd edn. New York: Raven.
24. Kenakin, T. (1997). Agonist-specific receptor conformations. Trends Pharmacol. Sci., 18, 416-417.
25. Lang, M.G., Noli., G. & Luscher, T.F. (1995). Effect of aging and hypertension on contractility of resistance arteries; modulation by endothelial factors. Am. J. Physiol., 269, H837-H844.
26. Le Noble, F.A., Schreurs, N.H., Van Straaten, H.W., Slaaf, D.W., Smits, J.F., Rogg, H. & Struliker-Boudier, H.A. (1993). Evidence for a novel angiotensin II receptor involved in angiogenesis in chick embryo chorioallantoic membrane. Am. J. Physiol., 264, R460-R465.
27. Leff, P., Scaramellini, C., Law, C. & McKechnie, K. (1997). A three-state receptor model of agonist action. Trends Pharmacol. Sci., 18, 355-362.
28. Lin, L. & Nasjletti, A. (1991). Role of endothelium-derived prostanoid in angiotensin II-induced vasoconstriction. Hypertension, 18, 158-164.
29. Liu, Y.J. (1993). Antagonist effect of losartan on angiotensin II induced contraction in five isolated smooth muscle assays. Eur. J. Pharmacol., 240, 147-154.
30. Manabe, K., Shirahase, H., Usui, H., Kurahashi, K. & Fujiwara, M. (1989). Endothelium-dependent contractions induced by angiotensin I and angiotensin II in canine cerebral artery. J. Pharmacol. Exp. Ther., 251, 317-320.
31. Martinez, M.C., Vila, J.M., Aldasoro, M., Medina, P., Flor, B. & Lluch, S. (1994). Relaxation of human isolated mesenteric arteries by vasopressin and desmopressin. Br. J. Pharmacol., 113, 419-424.
32. Mulvany, M.J. & Halpern, W. (1977). Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ. Res., 41, 19-26.
33. Munzenmaier, D.H. & Green, A.S. (1996). Opposing actions of angiotensin II on microvascular growth and arterial blood pressure. Hypertension., 27, 760-765.
34. Noda, M., Shibouta, Y., Inada, Y., Ojima, M., Wada, T., Sanada, T., Kubo, K., Kohara, Y., Naka, T. & Nishikawa, K. (1993). Inhibition of rabbit aortic angiotensin II (AII) receptor by CV-11974, a new nonpeptide AII antagonist. Biochem. Pharmacol., 46, 311-318.
35. Ojima, M., Inada, Y., Shibouta, Y., Wada, T., Sanada, T., Kubo, K. & Nishikawa, K. (1997). Candesartan (CV-11974) dissociates slowly from the angiotensin AT1 receptor. Eur. J. Pharmacol., 319, 137-146.
36. Prieto, D., Simonsen, U. & Nyborg, N.C. (1995). Regional involvement of an endothelium-derived contractile factor in the vasoactive actions of neuropeptide Y in bovine isolated retinal arteries. Br. J. Pharmacol., 116, 2729-2737.
37. Rang, H.P. & Ritter, J.M. (1970). On the mechanism of desensitization at cholinergic receptors. Mol. Pharmacol., 6, 357-382.
38. Rhaleb, N.E., Rouissi, N., Nantel, F., D'Orleans-Juste, P. & Regoli, D. (1991). DuP 753 is a specific antagonist for the angiotensin receptor. Hypertension, 17, 480-484.
39. Robertson, M.J., Dougall, I.G., Harper, D., McKechnie, K.C.W. & Leff, P. (1994). Agonist-antagonist interactions at angiotensin receptors: application of a two state receptor model. Trends Pharmacol. Sci., 15, 364-369.
40. Scheuer, D.A. & Perrone, M.H. (1993). Angiotensin type 2 receptors mediate depressor phase of biphasic pressure response to angiotensin. Am J. Physiol., 33, R917-R923.
41. Shibouta, Y., Inada, Y., Ojima, M., Wada, T., Noda, M., Sanada, T., Kubo, K., Kohara, Y., Naka, T. & Nishikawa, K. (1993). Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, CV-11974 and its prodrug, TCV-116. J. Pharmacol. Exp. Ther., 266, 114-120.
42. Timmermans, P.B.M.W.M., Wong, P.C., Chiu, A.T., Herblin, W.F., Benfield, P., Carini, D.J., Lee, R.J., Wexler, R.R., Saye, J.A.M. & Smith, R.D. (1993). Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol. Rev., 45, 205-251.
43. Tsutsumi, K. & Saavedra, J.M. (1991). Characterization of AT2 angiotensin II receptors in rat anterior cerebral arteries. Am. J. Physiol., 261, H667-H670.
44. Webb, M.L., Dickinson, K.F.J., Delaney, C.L., Liu, E.C.K., Serafino, R., Cohen, R.B., Monshizadegan, H. & Moreland, S. (1992). The endothelin receptor antagonist BQ 123 inhibits angiotensin II-induced contractions in rabbit aorta. Biochem. Biophys. Res. Commun., 185, 887-892.
45. Wong, P.C., Hart, S.D., Zaspel, A.M., Chiu, A.T., Ardecky, R.J., Smith, R.D. & Timmermans, P.B. (1990a). Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2). J. Pharmacol. Exp. Ther., 255, 584-592.
46. Wong, P.C., Price, W.A. JRR, Chiu, A.T., Duncia, J.V., Carini, D.J., Wexler, R.R., Johnson, A.L. & Timmermans, P.B. (1990b). Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent. J. Pharmacol. Exp. Ther., 255, 211-217.
47. Wu, X.C., Johns, E., Michael, J. & Richards, N.T. (1994). Interdependence of contractile rsponses of rat small mesenteric arteries on nitric oxide and cyclo-oxygenase and lipoxygenase products of arachidonic acid. Br. J. Pharmacol., 112, 360-368.
48. 1B receptor subtype. Biochem. Biophys. Res. Commun., 185, 204-210.
49. Zhang, J., Pfaffendore, M., Zhang, J.S. & Van Zwetten, P.A. (1995). Influence of the vascular endothelium on angiotensin II-induced contractions in rabbit renal artery. Fundam. Clin. Pharmacol., 9, 25-29.